Thesis Stock

Thesis offers personalized brain supplements focused on mental performance.

Sign up today and learn more about Thesis Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Thesis Stock

Thesis offers personalized brain supplements that cater to all types of brains. They create potent nutritional compounds to improve mental function and provide individualized suggestions depending on their customers' goals and brain chemistry.

Funding History

May 2023$8.4M
May 2023$5.1M

Management

Co-Founder and CEO

Daniel Freed

Head of Growth

William Dehnert

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo